ARTICLE | Distillery Therapeutics
Promoting expression of immune targets IFI16 and NLRC5 for melanoma
August 27, 2020 9:34 PM UTC
DISEASE CATEGORY: Cancer
INDICATION: Melanoma...
BCIQ Company Profiles
BCIQ Target Profiles
DISEASE CATEGORY: Cancer
INDICATION: Melanoma...
BCIQ Company Profiles
BCIQ Target Profiles
BCIQ Company Profiles
BCIQ Target Profiles